Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors

Conclusion: abnormal concentrations of brain metabolites and decreased glutamate plus glutamine concentration may play an important role in the pathophysiology of VRF-associated cognitive impairment. Brain metabolites detected by 1H MRS may serve as important markers for monitoring VRFs burden.

Source: Age and Ageing - August 25, 2014 Category: Geriatrics Authors: Sun, D., Zhang, J., Fan, Y., Liu, X., Gao, Y., Wu, G., Yan, Y., Zeng, J. Tags: Research Papers Source Type: research